Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for HCC Chemoprevention in Advanced Liver Fibrosis
NCT05028829Phase 2Recruiting
- Start
- May 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in hepatocellular carcinoma (HCC). Started May 2023; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05028829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05028829.